Mild cognitive impairment: Useful or not?

Alzheimer's and Dementia

Volumn 1, Issue 1, 2005, Pages 5-10

  Petersen, Ronald C ^a  

^a Mayo Clinic   (United States)

Author keywords

Aging; Alzheimer's disease; Mild cognitive impairment

Indexed keywords

ALPHA TOCOPHEROL; DONEPEZIL; GALANTAMINE; PIRACETAM; RIVASTIGMINE; ROFECOXIB;

AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEALTH INSURANCE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR DEPRESSION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEMORY DISORDER; NEUROIMAGING; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOMETRY; RETIREMENT; SYMPTOM; TREATMENT PLANNING;

EID: 33644790980     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2005.06.013     Document Type: Article

References (32)

1. K. Ritchie J. Touchon Mild cognitive impairment conceptual basis and current nosological status [see comments] Lancet 355 9199 2000 225-228
2. R.C. Petersen Conceptual overview R.C. Petersen Mild cognitive impairment Aging to Alzheimer's disease 2003 Oxford University Press, Inc New York 1-14
3. R.C. Petersen R. Doody A. Kurz et. al. Current concepts in mild cognitive impairment Arch Neurol 58 2001 1985-1992
4. B. Winblad K. Palmer M. Kivipelto et. al. Mild cognitive impairment - beyond controversies, towards a consensus J Intern Med 256 2004 240-246
5. M. Zaudig Prodromes and early detection of Alzheimer's disease M. Maj J.J. obez-Ibor M. Sartorius M. Sato A. Okasha Early detection and management of mental disorders 2005 John Wiley & Sons Hoboken, NJ 276-294
6. C.A. Luis D.A. Loewenstein A. Acevedo W.W. Barker R. Duara Mild cognitive impairment directions for future research Neurology 61 2003 438-444
7. V.A. Kral Senescent forgetfulness benign and malignant Can Med Assoc J 86 1962 257-260
8. T. Crook R.T. Bartus S.H. Ferris P. Whitehouse G.D. Cohen S. Gershon Age-associated memory impairment proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health Work Group Dev Neuropsychol 2 1986 261-276
9. G. Smith R.J. Ivnik R.C. Petersen J.F. Malec E. Kokmen E. Tangalos Age-associated memory impairment diagnoses problems of reliability and concerns for terminology Psychol Aging 6 4 1991 551-558
10. R. Levy Aging-associated cognitive decline Int Psychogeriatr 6 1994 63-68
11. A. LaRue Aging and neuropsychological assessment 1992 Plenum Press New York
12. R.C. Petersen G.E. Smith S.C. Waring R.J. Ivnik E.G. Tangalos E. Kokmen Mild cognitive impairment clinical characterization and outcome Arch Neurol 56 1999 303-308
13. C.R. Jack Jr R.C. Petersen Y.C. Xu et. al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 7 1999 1397-1403
14. M. Ganguli H.H. Dodge C. Shen S.T. DeKosky Mild cognitive impairment, amnestic type an epidemiologic study Neurology 63 2004 115-121
15. P.J. Visser P. Scheltens F.R. Verhey et. al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment J Neurol 246 6 1999 477-485
16. H. Hampel S.J. Teipel T. Fuchsberger et. al. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment Mol Psychiatry 9 2004 705-710
17. Y.E. Geda R.C. Petersen Clinical trials in mild cognitive impairment S. Gauthier J.L. Cummings Alzheimer's disease and related disorders annual 2001 2001 Martin Dunitz London 69-83
18. E.J. Mufson S.Y. Ma E.J. Cochran et. al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease J Comp Neurol 427 2000 19-30
19. K. Ritchie S. Artero J. Touchon Classification criteria for mild cognitive impairment a population-based validation study Neurology 56 2001 37-42
20. O.L. Lopez W.J. Jagust S.T. DeKosky et. al. Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study Arch Neurol 60 2003 1385-1389
21. S. Larrieu L. Letenneur J.M. Orgogozo et. al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort Neurology 59 2002 1594-1599
22. F.W. Unverzagt S. Gao O. Baiyewu et. al. Prevalence of cognitive impairment data from the Indianapolis Study of Health and Aging Neurology 57 2001 1655-1662
23. S.G. Mueller M.W. Weiner L.J. Thal R.C. Peterson C. Jack W. Jagust J.Q. Trojanowski A.W. Toga L. Beckett Ways toward an early diagnosis in Alzheimer's disease The Alzheimer's disease neuroimaging initiative Alz Dem J Alz Assoc 1 2005 55-66
24. R.C. Petersen J.C. Stevens M. Ganguli E.G. Tangalos J.L. Cummings S.T. DeKosky Practice parameMer: Early detection of dementia: mild cognitive impairment (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 9 2001 1133-1142
25. R.C. Petersen Mild cognitive impairment as a diagnostic entity J Intern Med 256 2004 183-194
26. P.J. Whitehouse E.T. Juengst Antiaging medicine and mild cognitive impairment practice and policy issues for geriatrics 2005 J Am Geriatr Soc (in press)
27. R. Petersen Mild cognitive impairment clinical trials Nature Reviews Drug Discovery 2 2003 646-653
28. R.C. Petersen R.G. Thomas M. Grundman et. al. Donepezil and vitamin E in the treatment of mild cognitive impairment N Engl J Med 352 2005 2379-2388
29. M. Gold S. Francke J.S. Nye et. al. Impact of APOE genotype on the efficacy of galantamine for the treatment of mild cognitive impairment Neurobiol Aging 25 2004 S521
30. P. Scheltens N.C. Fox F. Barkhof M. Gold Effect of galantamine treatment on brain atrophy as assessed by MRI in patients with mild cognitive impairment Neurobiol Aging 25 2004 S270
31. L.J. Thal S.H. Ferris L. Kirby A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment 2005 Neuropsychopharmacology (in press)
32. R.C. Petersen D.W. Dickson J.E. Parisi et. al. Neuropathologic substrate of mild cognitive impairment Neurobiol Aging 21 Suppl 2000 S198